Hassan Abolhassani

1. COURSES AND DEGREES:

2000-2003: Mathematic Diploma, Mofid High School, Tehran, Iran. 

2003-2004: Biology & Experimental Science Diploma, Sama High School, Tehran, Iran.

2008-2012: Master of Public Health (MPH), School of Health, Tehran University of Medical Sciences, Tehran, Iran. 

2012-2013: Master of Philosophy (MPhil), Research Accessory of Tehran University of Medical Sciences, Tehran, Iran. 

 

2. DOCTORAL DEGREES:

2004-2012: Medical Doctor (MD), School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. 

2014-2018: Philosophy of Doctoral (Ph.D.) on Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden.

 

3. POSTDOCTORAL FELLOWSHIP:

2018-2020: Postdoctoral Fellowship in Clinical Immunology, Karolinska Institutet, Stockholm, Sweden.

 

4. MERIT IN ESSENTIAL SCIENCE INDICATOR:

Honored as top 1% of highly cited scientific researchers in the field of Immunology, Essential Science Indicators (ESI, https://clarivate.com/).

5. AFFILIATIONS:

2004 - 2010: Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

2010 - now: Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

2014- 2021: Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden.

2021- now: Division of Clinical Immunology, Department Biosciences and Nutrition, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden.

 

6. CURRENT POSITION:

Assistant Professor of Clinical Immunology,  Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden

Leadership member of the steering committee at Junior Faculty, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden

 

7. SELECTED ACADEMIC DISTINCTIONS AND OTHER MERITS:

7.1 Bibliometric parameters

Articles in the peer-reviewed journals indexed in ISI and/or Pubmed: 290

H-index: 64, i10-index: 190

Total number of citations: 24828

Sum of the latest known journal impact factor: 5411.5

Updated full list of publications (articles, books, book chapters, oral presentations): https://staff.ki.se/people/hasabo

7.2 Merit in Karolinska Institutet (KI) and Stockholms läns landsting (SLL):

Five stars scientist: First decentile of both Karolinska Institutet (KI) and Stockholms läns landsting (SLL) regarding “number of citations”, “average journal impact for top publications”, “aggregated journal impact factors”, “number of publications”, "citations average for top publications" and regarding “world’s most highly cited publications (count top 5%)”  based on bibliometrics.ki.se analysis (2014-2021)

7.3 Other academic merits

2010- Grant from the International Congress of Immunology, Kobe, Japan.

2011- Prominent Researcher Award, Tehran University of Medical Sciences, Tehran, Iran.

2012- Grant from European Society for Immunodeficiencies, Florence, Italy.

2013- Distinctive Elite Medical Doctoral student (MD) of Iran, Tehran, Iran.

2013- Paramount Young Scientists of the Country in Medical Sciences, Tehran, Iran.

2014- The 1st Rank of the Best Researcher and Best Comprehensive Student in the First Student Avicenna Festival, Tehran, Iran.

2014- Grant from Primary Immunodeficiency Organization (PIO), 2014 års forskningsstöd, Stockholm, Sweden.

2015- Distinctive Elite Ph.D. Doctoral Student of Iran, Tehran, Iran.

2018- Top 10 Ph.D. thesis of Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden.

2018-now- Honored as 1% highly cited scientific researchers in the field of Immunology, Essential Science Indicators (ESI, https://clarivate.com).

2020-now-World's Top 2% widely cited scientists based on Stanford University ranking and Scopus/Elsevier database, selecting 200,000 researchers from more than 10 million scientists (since 1788 until now) with 22 scientific fields and 176 subfields taken into account.

2018- now- Top three clinical immunologists of Iran, Essential Science Indicators (ESI, https://clarivate.com).

2019- now- Top three clinical immunologists of Sweden, Essential Science Indicators (ESI, https://clarivate.com).
2020- now- Ranked among the top World Experts in the following medical topics based on Expertscape (https://expertscape.com/): Primary Immunodeficiency Diseases,  Common Variable Immunodeficiency, Dysgammaglobulinemia, Agammaglobulinemia, Hyper-IgM Immunodeficiency, IgA Deficiency, Severe Combined Immunodeficiency, DNA Repair-Deficiency, Immunologic Syndromes, Lymphoproliferative Disorders, Intravenous Immunoglobulins, Inborn Genetic Diseases, Ataxia Telangiectasia.

8. RESEARCH GRANTS OBTAINED IN OPEN COMPETITION As the main applicant:

Jeffrey Modell Diagnostic and Research Center (2020),  KI Research Foundation Grants (2020), Åke Wibergs Foundation (2019), Jonas Söderquist scholarship (2018), Marcus Borgströms Foundation (2018), Ruth and Richard Julin Foundation (2017-2018), Alex and Eva Wallström Foundation (2017), ìShizu Matsumuraîs Donation (2017).

9. SCIENTIFIC COLLABORATIONS:

European Society for Immunodeficiencies, PID J project steering committee Jeffrey Modell Foundation's, Clinical Immunology Society, Henry Kunkel Society, Taskforce- World Health Organization, Coordination of Swedish cohort of patients with primary immunodeficiency, Collaboration with government agencies regarding health policy-making for immunodeficiency and measuring the burden of the disease.

10. EVALUATION OF OTHERS’ WORK:

Serving as editorial board and reviewer for international evaluations: Please see the profile in Publons: https://publons.com/a/1446038/

11. PREVIOUS SUPERVISIONS AND TEACHING:

Students supervised up to the defense of the candidate’s, with the applicant serving as co-supervisor: 3 master students, 3 MD students, 2 PhD students, 4 pediatric specialists, 3 clinical immunologist subspecialists.

 

12. ENGLISH PUBLICATIONS: # shared the first author. * Corresponding author

1-      Zuo F, Abolhassani H#, Du L, Piralla A, Bertoglio F, de Campos-Mata L, Wan H, Schubert M, Cassaniti I, Wang Y, Sammartino JC, Sun R, Vlachiotis S, Bergami F, Kumagai-Braesch M, Andréll J, Zhang Z, Xue T, Wenzel EV, Calzolai L, Varani L, Rezaei N, Chavoshzadeh Z, Baldanti F, Hust M, Hammarström L, Marcotte H, Pan-Hammarström Q. Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant. Nat Commun.2022. Epub (PMID: 35562366).

2-      Farzadfar F, Naghavi M, Sepanlou SG, Saeedi Moghaddam S, Dangel WJ, Weaver ND, Aminorroaya A, Azadnajafabad S, Koolaji S, Mohammadi E, Rezaei N, Abbas J, Abbasi B, Abbasifard M, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abbastabar H, Abdoli A, Abdollahi M, Abdollahzade A, Abolhassani H, et al. Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022. Apr 23;399(10335):1625-1645.

3-      Armocida B, Monasta L, Sawyer SM, Bustreo F, Segafredo G, Castelpietra G, Ronfani L, Pasovic M, Hay SI, Abila DB, Abolhassani H, et al. Burden of non-communicable diseases among adolescents aged 10-24 years in the EU, 1990-2019: a systematic analysis of the Global Burden of Diseases Study 2019. Lancet Child Adolesc Health. 2022 Jun;6(6):367-383.

4-      Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, Harvey JD, Henrikson HJ, Lu D, Pennini A, Xu R, Ababneh E, Abbasi-Kangevari M, Abbastabar H, Abd-Elsalam SM, Abdoli A, Abedi A, Abidi H, Abolhassani H, et al. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2022. Mar 1;8(3):420-444.

5-      Tyrovolas S, Stergachis A, Krish VS, Chang AY, Skirbekk V, Dieleman JL, Chatterji S, Abd-Allah F, Abdollahi M, Abedi A, Abolhassani H, et al. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study. BMJ. 2022 Mar 10;376:e068208.

6-      Alvarez EM, Force LM, Xu R, Compton K, Lu D, Henrikson HJ, Kocarnik JM, Harvey JD, Pennini A, Dean FE, Fu W, Vargas MT, Keegan TH, Ariffin H, Barr RD, Erdomaeva YA, Gunasekera DS, John-Akinola YO, Ketterl TG, Kutluk T, Malogolowkin MH, Mathur P, Radhakrishnan V, Ries LA, Rodriguez-Galindo C, Sagoyan GB, Sultan I, Abbasi B, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abbastabar H, Abdelmasseh M, Abd-Elsalam S, Abdoli A, Abebe H, Abedi A, Abidi H, Abolhassani H, et al. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Oncol. 2022 Jan;23(1):27-52.

7-      Cousin E, Duncan BB, Stein C, Ong KL, Vos T, Abbafati C, Abbasi-Kangevari M, Abdelmasseh M, Abdoli A, Abd-Rabu R, Abolhassani H, et al. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019. Lancet Diabetes Endocrinol. 2022 Mar;10(3):177-192.

8-      Ledesma JR, Ma J, Vongpradith A, Maddison ER, Novotney A, Biehl MH, LeGrand KE, Ross JM, Jahagirdar D, Bryazka D, Feldman R, Abolhassani H, et al. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019. Lancet Infect Dis.2022; 22(2):222-241.

9-      Dimitrova D, Nademi Z, Maccari ME, Ehl S, Uzel G, Tomoda T, Okano T, Imai K, Carpenter B, Ip W, Rao K, Worth AJJ, Laberko A, Mukhina A, Néven B, Moshous D, Speckmann C, Warnatz K, Wehr C, Abolhassani H, Aghamohammadi A, Bleesing JJ, Dara J, Dvorak CC, Ghosh S, Kang HJ, Markelj G, Modi A, Bayer DK, Notarangelo LD, Schulz A, Garcia-Prat M, Soler-Palacín P, Karakükcü M, Yilmaz E, Gambineri E, Menconi M, Masmas TN, Holm M, Bonfim C, Prando C, Hughes S, Jolles S, Morris EC, Kapoor N, Koltan S, Paneesha S, Steward C, Wynn R, Duffner U, Gennery AR, Lankester AC, Slatter M, Kanakry JA. International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome. J Allergy Clin Immunol. 2022 Jan;149(1):410-421.

10-  Zhang Q, Matuozzo D, Le Pen J, Lee D, Moens L, Asano T, Bohlen J, Liu Z, Moncada-Velez M, Kendir-Demirkol Y, Jing H, Bizien L, Marchal A, Abolhassani H, Delafontaine S, Bucciol G; COVID Human Genetic Effort, Bayhan GI, Keles S, Kiykim A, Hancerli S, Haerynck F, Florkin B, Hatipoglu N, Ozcelik T, Morelle G, Zatz M, Ng LFP, Lye DC, Young BE, Leo YS, Dalgard CL, Lifton RP, Renia L, Meyts I, Jouanguy E, Hammarström L, Pan-Hammarström Q, Boisson B, Bastard P, Su HC, Boisson-Dupuis S, Abel L, Rice CM, Zhang SY, Cobat A, Casanova JL. Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia. Journal of Experimental Medicine. 2022. Aug 1;219(8):e20220131.

11-  Bastard P, Vazquez S, Liu J, Laurie MT, Wang CY, Gervais A, Le Voyer T, Bizien L, Zamecnik C, Philippot Q, Rosain J, Catherinot E, Willmore A, Mitchell AM, Bair R, Garçon P, Kenney H, Fekkar A, Salagianni M, Poulakou G, Siouti E, Sahanic S, Tancevski I, Weiss G, Nagl L, Manry J, Duvlis S, Arroyo-Sánchez D, Paz Artal E, Rubio L, Perani C, Bezzi M, Sottini A, Quaresima V, Roussel L, Vinh DC, Reyes LF, Garzaro M, Hatipoglu N, Boutboul D, Tandjaoui-Lambiotte Y, Borghesi A, Aliberti A, Cassaniti I, Venet F, Monneret G, Halwani R, Sharif-Askari NS, Danielson J, Burrel S, Morbieu C, Stepanovskyy Y, Bondarenko A, Volokha A, Boyarchuk O, Gagro A, Neuville M, Neven B, Keles S, Hernu R, Bal A, Novelli A, Novelli G, Saker K, Ailioaie O, Antolí A, Jeziorski E, Rocamora-Blanch G, Teixeira C, Delaunay C, Lhuillier M, Le Turnier P, Zhang Y, Mahevas M, Pan-Hammarström Q, Abolhassani H, Bompoil T, Dorgham K; COVID HGE consortium †; French COVID study group †; COMET consortium †, Gorochov G, Laouenan C, Rodríguez-Gallego C, Ng LFP, Renia L, Pujol A, Belot A, Raffi F, Allende LM, Martinez-Picado J, Ozcelik T, Keles S, Imberti L, Notarangelo LD, Troya J, Solanich X, Zhang SY, Puel A, Wilson MR, Trouillet-Assant S, Abel L, Jouanguy E, Ye CJ, Cobat A, Thompson LM, Andreakos E, Zhang Q, Anderson MS, Casanova JL, DeRisi JL. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs. Sci Immunol. 2022 Jun 14:eabp8966.

12-  XX, Ogishi M, Arias AA, Yang R, Han JE, Zhang P, et al. Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency. Journal of Experimental Medicine. 2022. Inpress.

13-  Sefer AP, Abolhassani H, Ober F, Kayaoglu B, Bilgic Eltan S, Kara A, Erman B, Surucu Yilmaz N, Aydogmus C, Aydemir S, Charbonnier Lm, Kolukisa B, Azizi G, Delavari S, Momen T, Aliyeva S, Kendir Demirkol Y, Tekin S, Kiykim A, Baser Of, Cokugras H, Gursel M, Karakoc-aydiner E, Ozen A, Krappmann D, Chatila Ta, Rezaei N, Baris S. Expanding the Clinical and Immunological Phenotypes and Natural History of MALT1 Deficiency. J Clin Immunol. 2022. Apr;42(3):634-652. Journal of Experimental Medicine. 2022.

14-  Fekrvand S, Delavari S, Chavoshzadeh Z, Sherkat R, Mahdaviani SA, Sadeghi Shabestari M, Azizi G, Arzanian MT, Shahin Shamsian B, Eskandarzadeh S, Eslami N, Rae W, Condino-Neto A, Mohammadi J, Abolhassani H, Yazdani R, Aghamohammadi A. The First Iranian Cohort of Pediatric Patients with Activated Phosphoinositide 3-Kinase-δ (PI3Kδ) Syndrome (APDS). Immunol Invest. 2022. Apr;51(3):644-659.

15-  Zarezadeh Mehrabadi A, Aghamohamadi N, Abolhassani H, Aghamohammadi A, Rezaei N, Yazdani R. Comprehensive Assessment of Skin Disorders in Patients with Common Variable Immunodeficiency (CVID). J Clin Immunol. 2022. Apr;42(3):653-664.

16-  Khanmohammadi S, Shad TM, Delavari S, Shirmast P, Bagheri Y, Azizi G, Aghamohammadi A, Abolhassani H, Yazdani R, Rezaei N. Evaluation of Specific Antibody Responses in Patients with Selective IgA Deficiency and Ataxia Telangiectasia. Endocr Metab Immune Disord Drug Targets. 2022. Epub (PMID: 35135457).

17-  Salami F, Fekrvand S, Yazdani R, Shahkarami S, Azizi G, Bagheri Y, Delavari S, Shariati S, Mahdaviani SA, Abolhassani H, Samadi M, Aghamohammadi A. Evaluation of expression of LRBA and CTLA-4 proteins in Common variable immunodeficiency patients. Immunol Invest. 2022;51(2):381-394.

18-  Salami F, Shariati S, Rasouli SE, Delavari S, Tavakol M, Sadri H, Asghari B, Yazdani R, Rezaei N, Abolhassani H, Azizi G. The Effects of Stimulation with PMA/Ionomycin on CD4+ T cell Proliferation and Surface CD4 Molecule Modulation of Patients with LRBA Deficiency and CVID with the Unsolved Genetic Defect. Endocr Metab Immune Disord Drug Targets. 2022. Epub (PMID: 34886783).

19-  Soltani M, Rezaei M, Fekrvand S, Ganjalikhani-Hakemi M, Abolhassani H, Yazdani R. Role of Rare Immune Cells in Common Variable Immunodeficiency. Pediatr Allergy Immunol. 2022 Feb;33(2):e13725.

20-  Fang M*, Su Z*, Abolhassani H*, Zhang W, Jiang C, Cheng B, Luo L, Wu J, Wang S, Lin L, Wang X, Wang L, Aghamohammadi A, Li T, Zhang X, Hammarström L, Liu X. T cell repertoire abnormality in immunodeficiency patients with DNA repair and methylation defects. J Clin Immunol. 2022;42(2):375-393.

21-  Mohtashami M, Razavi A, Abolhassani H, Aghamohammadi A, Yazdani R. Primary Immunodeficiency and Thrombocytopenia. Int Rev Immunol. 2022;41(2):135-159.

22-  Bagheri et al. Evaluation of effective factors on IL-10 signaling in B cells in selective IgA deficiency patients. European Cytokine Network. 2022. Inpress.

23-  Sharifinejad N, Azizi G, Behniafard N, Zaki-Dizaji M, Jamee M, Yazdani R, Abolhassani H, Aghamohammadi A. Protein Kinase C-Delta Defect in Autoimmune Lymphoproliferative Syndrome-Like Disease: First Case from the National Iranian Registry and Review of the Literature. Immunol Invest. 2022;51(2):331-342.

24-  Amirifar P, Mehrmohamadi M, Ranjouri MR, Akrami SM, Rezaei N, Saberi A, Yazdani R, Abolhassani H*, Aghamohammadi A. Genetic Risk Variants for Class Switching Recombination Defects in Ataxia-Telangiectasia Patients. J Clin Immunol. 2022;42(1):72-84.

25-  Rasouli SE, Tavakol M, Sadri H, Chavoshzadeh Z, Alireza Mahdaviani S, Delavari S, Jamee M, Kalantari A, Seifi Alan M, Aghamahdi F, Abolhassani H, Yazdani R, Rezaei N, Azizi G. The spectrum of inborn errors of immunity: a single tertiary center retrospective study in Alborz, Iran. Eur Ann Allergy Clin Immunol. 2022. Epub (PMID: 34918886).

26-  Tofighi Zavareh F, Mirshafiey A, Yazdani R, Keshtkar AA, Abolhassani H, Mahdaviani SA, Habibi S, Sohani M, Rezaei N, Aghamohammadi A.Immunophenotypic and functional analysis of lymphocyte subsets in common variable immunodeficiency patients without monogenic defects. Scand J Immunol. 2022. Epub (PMID: 35305035).

27-  Sharifinejad N, Zaki-Dizaji M, Sepahvandi R, Fayyaz F, Vilela MMDS, ElGhazali G, Abolhassani H, Ochs HD, Azizi G. The clinical, molecular, and therapeutic features of patients with IL10/IL10R deficiency: a systematic review. Clin Exp Immunol. Epub (PMID: 35481870).

28-  Marcotte H, Piralla A, Zuo F, Du L, Cassaniti I, Wan H, Kumagai-Braesh M, Andréll J, Percivalle E, Sammartino JC, Wang Y, Vlachiotis S, Attevall J, Bergami F, Ferrari A, Colaneri M, Vecchia M, Sambo M, Zuccaro V, Asperges E, Bruno R, Oggionni T, Meloni F, Abolhassani H, Bertoglio F, Schubert M, Calzolai L, Varani L, Hust M, Xue Y, Hammarström L, Baldanti F, Pan-Hammarström Q. Immunity to SARS-CoV-2 up to 15 months after infection. iScince. 2022. 25(2):103743.

29-  Fekrvand S, Khanmohammadi S, Abolhassani H, Yazdani R. B-and T-cell Subset Abnormalities in Monogenic Common Variable Immunodeficiency. Front Immunol. 2022 Jun 15;13:912826.

30-  XXX. Disease progression of WHIM syndrome in an international cohort of 66 pediatric and adult patients. J Clin Immunol. 2022. Inpress.

31-  XXX. Detrimental NFKB1 missense variants affecting the Rel-homology domain of p105/p50. Frontiers in Immunology. 2022. Inpress.

32-  Azangou-Khyavy M, Saeedi Moghaddam S, Rezaei N, Esfahani Z, Rezaei N, Azadnajafabad S, Rashidi M, Mohammadi E, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abolhassani H, et al. National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019. Sci Rep. 2022 Aug 2;12(1):13231.

33-  Edwards E, Ameratunga R, Abolhassani H, Maglione PJ. Editorial: Contemporary Challenges in Diagnosis and Treatment of Predominantly Antibody Deficiency. Frontiers in Immunology. 2022. Inpress.

34-  Wang Y, Abolhassani H, Hammarström L, Pan-Hammarström Q. SARS-CoV-2 infection in patients with inborn errors of immunity due to DNA repair defects. Acta Biochimica et Biophysica Sinica. 2022. Epub (PMID: 35713311).

35-  Fang M, Su Z, Abolhassani H, Itan Y, Jin X, Hammarström L. VIPPID: a gene-specific single nucleotide variant pathogenicity prediction tool for Primary Immunodeficiency Diseases. Briefings in Bioinformatics. 2022 May 23;bbac176 (PMID: 35598327).

36-  Maródi L, Abolhassani H, J Project Study group et al. A rose amongst the thorns: the mission of the J Project in a conflictual world. J Clin Immunol. 2022. Epub (PMID: 35532839).

37-  Ye X, Maglione PJ, Wehr C, Li X, Wang Y, Abolhassani H, Deripapa E, Liu D, Borte S, Du L, Wan H, Plötner A, Giannoula Y, Ko HM, Hou Y, Zhu S, Grossman JK, Sander B, Grimbacher B, Hammarström L, Fedorova A, Rosenzweig S, Shcherbina A, Wu K, Warnatz K, Cunningham-Rundles C, Pan-Hammarström Q et al. Genomic characterization of lymphomas in patients with inborn errors of immunity. Blood Advances.2022. Epub (PMID: 35687490).

38-  Abolhassani H, Landegren N, Bastard P, Materna M, Modaresi M, Du L, Aranda-Guillén M, Sardh F, Zuo F, Zhang P, Marcotte H, Marr N, Khan T, Ata M, Al-Ali F, Pescarmona R, Belot A, Béziat V, Zhang Q, Casanova JL, Kämpe O, Zhang SY, Hammarström L, Pan-Hammarström Q. Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome. J Clin Immunol. 2022 Apr;42(3):471-483.

39-  Abolhassani H, Vosughimotlagh A, Asano T, Landegren N, Boisson B, Delavari S, Bastard P, Aranda-Guillén M, Wang Y, Zuo F, Sardh F, Marcotte H, Du L, Zhang SY, Zhang Q, Rezaei N, Kämpe O, Casanova JL, Hammarström L, Pan-Hammarström Q. X-linked TLR7 deficiency underlies critical COVID-19 pneumonia in a male patient with ataxia-telangiectasia. J Clin Immunol. 2022. 42(1):1-9.

40-  Paulson KR, Kamath AM, Alam T, Bienhoff K, Abady GG, Abbas J, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abd-Elsalam SM, Abdoli A, Abedi A, Abolhassani H, et al. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. Lancet. 2021 Sep 4;398(10303):870-905.

41-  Sbarra AN, Rolfe S, Nguyen JQ, Earl L, Galles NC, Marks A, Abbas KM, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A, Abdollahi M, Abegaz KH, Abiy HA, Abolhassani H, et al. Mapping routine measles vaccination in low- and middle-income countries. Nature. 2021 Jan;589(7842):415-419.

42-  Galles NC, Liu PY, Updike RL, Fullman N, Nguyen J, Rolfe S, Sbarra AN, Schipp MF, Marks A, Abady GG, Abbas KM, Abbasi SW, Abbastabar H, Abd-Allah F, Abdoli A, Abolhassani H, et al. Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1. Lancet. 2021 Aug 7;398(10299):503-521.

43-  Delavari S, Abolhassani H^#*, et al. Impact of SARS CoV-2 Pandemic on Patients with Primary Immunodeficiency. J Clin Immunol. 2021 Feb;41(2):345-355.

44-  Amirifar P, Ranjouri MR, Pashangzadeh S, Lavin M, Yazdani R, Shad TM, Mehrmohamadi M, Salami F, Delavari S, Moamer S, Aghamohammadi A, Akrami SM, Abolhassani H*. The spectrum of ATM gene mutations in Iranian patients with ataxia-telangiectasia. Pediatr Allergy Immunol. 2021 Aug;32(6):1316-1326.

45-  Micah AE, Cogswell IE, Cunningham B, Ezoe S, Harle AC, Maddison ER, McCracken D, Nomura S, Simpson KE, Stutzman HN, Tsakalos G, Wallace LE, Zhao Y, Zende RR, Abbafati C, Abdelmasseh M, Abedi A, Abegaz KH, Abhilash ES, Abolhassani H, et al. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050. Lancet. 2021 Oct 9;398(10308):1317-1343.

46-  Pillay BA, Fusaro M, Gray PE, Statham AL, Burnett L, Bezrodnik L, Kane A, Tong WWY, Abdo C, Winter S, Chevalier S, Levy R, Masson C, Schmitt Y, Bole-Feysot C, Malphettes M, Macintyre E, de Villartay JP, Ziegler JB, Smart JM, Peake J, Aghamohammadi A, Hammarström L, Abolhassani H, Picard C, Fischer A, Latour S, Neven B, Tangye S, Ma CS. Somatic reversion of pathogenic DOCK8 variants alters lymphocyte differentiation and function to effectively cure DOCK8 deficiency. J Clin Invest. 2021 Feb 1;131(3):e142434.

47-  Aghamohammadi A, Rezaei N, Yazdani R, Delavari S, Kutukculer N, Topyildiz E, Ozen A, Baris S, Karakoc-Aydiner E, Kilic SS, Kose H, Gulez N, Genel F, Reisli I, Djenouhat K, Tahiat A, Boukari R, Ladj S, Belbouab R, Ferhani Y, Belaid B, Djidjik R, Kechout N, Attal N, Saidani K, Barbouche R, Bousfiha A, Sobh A, Rizk R, Elnagdy MH, Al-Ahmed M, Al-Tamemi S, Nasrullayeva G, Adeli M, Al-Nesf M, Hassen A, Mehawej C, Irani C, Megarbane A, Quinn J; MENA-I. E. I. Study Group, Maródi L, Modell V, Modell F, Al-Herz W, Geha RS, Abolhassani H*. Consensus Middle East and North Africa Registry on Inborn Errors of Immunity. J Clin Immunol. 2021 Aug;41(6):1339-1351.

48-  Moeini Shad T, Yazdani R, Amirifar P, Delavari S, Heidarzadeh Arani M, Mahdaviani SA, Sadeghi-Shabestari M, Aghamohammadi A, Rezaei N, Abolhassani H. Atypical Ataxia Presentation in Variant Ataxia Telangiectasia: Iranian Case-Series and Review of the Literature. Front. Immunol. 2021. 12:779502.

49-  Neehus AL, Moriya K, Nieto-Patlán A, Le Voyer T, Lévy R, Özen A, Karakoc-Aydiner E, Baris S, Yildiran A, Altundag E, Roynard M, Haake K, Migaud M, Dorgham K, Gorochov G, Abel L, Lachmann N, Dogu F, Haskologlu S, İnce E, El-Benna J, Uzel G, Kiykim A, Boztug K, Roderick MR, Shahrooei M, Brogan PA, Abolhassani H, Hancioglu G, Parvaneh N, Belot A, Ikinciogullari A, Casanova JL, Puel A, Bustamante J. Impaired respiratory burst contributes to infections in PKCδ-deficient patients. J Exp Med. 2021 Sep 6;218(9):e20210501.

50-  Català-Moll F, Ferreté-Bonastre AG, Li T, Weichenhan D, Lutsik P, Ciudad L, Álvarez-Prado ÁF, Rodríguez-Ubreva J, Klemann C, Speckmann C, Vilas-Zornoza A, Abolhassani H, Martínez-Gallo M, Dieli-Crimi R, Rivière JG, Martín-Nalda A, Colobran R, Soler-Palacín P, Kracker S, Hammarström L, Prosper F, Durandy A, Grimbacher B, Plass C, Ballestar E. Activation-induced deaminase is critical for the establishment of DNA methylation patterns prior to the germinal center reaction. Nucleic Acids Res. 2021 May 21;49(9):5057-5073.

51-  Asano T, Boisson B, Onodi F, Matuozzo D, Moncada-Velez M, Maglorius Renkilaraj MRL, Zhang P, Meertens L, Bolze A, Materna M, Korniotis S, Gervais A, Talouarn E, Bigio B, Seeleuthner Y, Bilguvar K, Zhang Y, Neehus AL, Ogishi M, Pelham SJ, Le Voyer T, Rosain J, Philippot Q, Soler-Palacín P, Colobran R, Martin-Nalda A, Rivière JG, Tandjaoui-Lambiotte Y, Chaïbi K, Shahrooei M, Darazam IA, Olyaei NA, Mansouri D, Hatipoğlu N, Palabiyik F, Ozcelik T, Novelli G, Novelli A, Casari G, Aiuti A, Carrera P, Bondesan S, Barzaghi F, Rovere-Querini P, Tresoldi C, Franco JL, Rojas J, Reyes LF, Bustos IG, Arias AA, Morelle G, Christèle K, Troya J, Planas-Serra L, Schlüter A, Gut M, Pujol A, Allende LM, Rodriguez-Gallego C, Flores C, Cabrera-Marante O, Pleguezuelo DE, de Diego RP, Keles S, Aytekin G, Akcan OM, Bryceson YT, Bergman P, Brodin P, Smole D, Smith CIE, Norlin AC, Campbell TM, Covill LE, Hammarström L, Pan-Hammarström Q, Abolhassani H, Mane S, Marr N, Ata M, Al Ali F, Khan T, Spaan AN, Dalgard CL, Bonfanti P, Biondi A, Tubiana S, Burdet C, Nussbaum R, Kahn-Kirby A, Snow AL; COVID Human Genetic Effort; COVID-STORM Clinicians; COVID Clinicians; Imagine COVID Group; French COVID Cohort Study Group; CoV-Contact Cohort; Amsterdam UMC Covid-; Biobank; NIAID-USUHS COVID Study Group, Bustamante J, Puel A, Boisson-Dupuis S, Zhang SY, Béziat V, Lifton RP, Bastard P, Notarangelo LD, Abel L, Su HC, Jouanguy E, Amara A, Soumelis V, Cobat A, Zhang Q, Casanova JL. X-linked recessive TLR7 deficiency in 1% of men under 60 years with life-threatening COVID-19. Science Immunology. 2021 Aug 19;6(62):eabl4348.

52-  Ebrahimi H, Aryan Z, Moghaddam SS, Bisignano C, Rezaei S, Pishgar F, Force LM, Abolhassani H, et al. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Respir Med. 2021 Sep;9(9):1030-1049.

53-  Kinyoki D, Osgood-Zimmerman AE, Bhattacharjee NV, Schaeffer LE, Lazzar-Atwood A, LuD, Ewald SB, Donkers KM, Letourneau ID, Collison M, Schipp MF, Abajobir A, Abbasi S, Abbasi N, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A, Abd-Elsalam SM, Abdoli A, Abdollahpour I, Abedi A, Abolhassani H, et al. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018. Nat Med. 2021 Oct;27(10):1761-1782.

54-  Ward JL, Azzopardi PS, Francis KL, Santelli JS, Skirbekk V, Sawyer SM, Kassebaum NJ, Mokdad SH, Hay SI, Abd-Allah F, Abdoli A, Abdollahi M, Abedi A, Abolhassani H, et al. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2021 Oct 30;398(10311):1593-1618.

55-  Thalhammer J, Kindle G, Nieters A, Rusch S, Seppänen MRJ, Fischer A, Grimbacher B, Edgar D, Buckland M, Mahlaoui N, Ehl S; ESID Registry Working Party (Iran: Abolhassani H, Rezaei N, Aghamohammadi A). Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations. J Allergy Clin Immunol. 2021 Nov;148(5):1332-1341.

56-  Azizi G, Tavakol M, Yazdani R, Delavari S, Moeini Shad T, Rasouli SE, Jamee M, Pashangzadeh S, Kalantari A, Shariat M, Shafiei A, Mohammadi J, Hassanpour G, Chavoshzadeh Z, Mahdaviani SA, Momen T, Behniafard N, Nabavi M, Bemanian MH, Arshi S, Molatefi R, Sherkat R, Shirkani A, Alyasin S, Jabbari-Azad F, Ghaffari J, Mesdaghi M, Ahanchian H, Khoshkhui M, Eslamian MH, Cheraghi T, Dabbaghzadeh A, Nasiri Kalmarzi R, Esmaeilzadeh H, Tafaroji J, Khalili A, Sadeghi-Shabestari M, Darougar S, Moghtaderi M, Ahmadiafshar A, Shakerian B, Heidarzadeh M, Ghalebaghi B, Fathi SM, Darabi B, Fallahpour M, Mohsenzadeh A, Ebrahimi S, Sharafian S, Vosughimotlagh A, Tafakoridelbari M, Rahimi Haji-Abadi M, Ashournia P, Razaghian A, Rezaei A, Salami F, Shirmast P, Bazargan N, Mamishi S, Ali Khazaei H, Negahdari B, Shokri S, Nabavizadeh SH, Bazregari S, Ghasemi R, Bayat S, Eshaghi H, Rezaei N, Abolhassani H*, Aghamohammadi A. Autoimmune Autoimmune manifestations among 461 patients with monogenic inborn errors of immunity. 2021. Pediatr Allergy Immunol. 2021 Aug;32(6):1335-1348.

57-  Amirifar P, Mozdarani H, Yazdani R, Kiaei F, Moeini Shad T, Shahkarami S, Abolhassani H, Delavari S, Sohani M, Rezaei A, Hassanpour G, Akrami SM, Aghamohammadi A. Effect of Class Switch Recombination Defect on the Phenotype of Ataxia-Telangiectasia Patients. Immunol Invest. 2021 Feb;50(2-3):201-215.

58-  Kiaee F, Zaki-Dizaji M, Hafezi N, Almasi-Hashiani A, Hamedifar H, Sabzevari A, Shirkani A, Zian Z, Jadidi-Niaragh F, Aghamahdi F, Goudarzvand M, Yazdani R, Abolhassani H, Aghamohammadi A, Azizi G. Clinical, Immunologic, and Molecular Spectrum of Patients with Immunodeficiency, Centromeric instability, and Facial anomalies (ICF) syndrome: a Systematic Review. Endocr Metab Immune Disord Drug Targets. 2021;21(4):664-672.

59-  Esmaeilzadeh H, Askarisarvestani A, Hosseini N, Samimi S, Shafiei A, Mahdaviani SA, Eslami N, Chavoshzadeh Z, Fallahi M, Khakbazanfard N, Shabestari MS, Aleyasin S, Nabavizadeh SH, Cheraghi T, Kalantari A, Ahmadiafshar A, Safari M, Eslamian MH, Molatefi R, Shirkani A, Heidarzadeh M, Tavakol M, Bemanian MH, Arshi S, Nabavi M, Shokri S, Shahhosseini B, Mortazavi N, Nakhaei P, Nazari F, Fallahpour M, Ahanchian H, Moazzen N, Khoshkhui M, Motlagh AV, Aghamohammadi A, Abolhassani H, Yazdani R, Rezaei N. Adverse Reactions in a Large Cohort of Patients with Inborn Errors of Immunity Receiving Intravenous Immunoglobulin. Clin Immunol. 2021 Sep;230:108826.

60-   Tofighi Zavareh F, Mirshafiey A, Yazdani R, Keshtkar AA, Abolhassani H, Bagheri Y, Rezaei A, Delavari S, Rezaei N, Aghamohammadi A. Lymphocytes subsets in correlation with clinical profile in CVID patients without monogenic defects. Expert Rev Clin Immunol. 2021 Sep;17(9):1041-1051.

61-  Safarirad M, Ganji AA, Fekrvand S, Yazdani R, Motlagh AV, Abolhassani H, Aghamohammadi A. The First Case Report of Kabuki Syndrome from the National Iranian Registry of Primary Immunodeficiencies. Endocr Metab Immune Disord Drug Targets. 2021;21(11):2099-2103.

62-  Amirifar P, Ranjouri MR, Abolhassani H, Moeini Shad T, Almasi-Hashiani A, Azizi G, Moamer S, Aghamohammadi A, Yazdani R. Clinical, Immunological and Genetic findings in Patients with UNC13D Deficiency (FHL3): a Systematic Review. Pediatr Allergy Immunol. 2021. Jan;32(1):186-197.

63-  Babaha F, Yazdani R, Shahkarami S, Hamidi Esfahani Z, Abolhassani H, Sadr M, Zavaran Hosseini A, Aghamohammadi A. Evaluation of miR-210 Expression in Common Variable immunodeficiency Patients with Unsolved Genetic Defect. Allergologia et immunopathologia. 2021 Mar 1;49(2):84-93.

64-  Hamidi Esfahani Z, Yazdani R, Shahkarami S, Babaha F, Abolhassani H, Sadr M, Pourfathollah AA, Aghamohammadi A.Evaluation of MicroRNA-125b-5p and transcription factors BLIMP1 and IRF4 Expression in Unsolved Common Variable Immunodeficiency Patients. Iran J Allergy Asthma Immunol. 2021 Dec 8;20(6):700-710.

65-  Nejatbakhsh F, Zareian MA, Yaseliani M, Abolhassani H*. Evidence-Based Immunotherapeutic Effects of Herbal Compounds on Humoral Immunity; Ancient and New Approaches. Chin J Integr Med. 2021 Apr;27(4):313-320.

66-  MoeiniShad T, Yousefi B, Amirifar P, Delavari S, Rae W, Kokhaei P, Abolhassani H, Aghamohammadi A, Yazdani R. Variable Abnormalities in T and B Cell Subsets in Ataxia Telangiectasia. J Clin Immunol. 2021 Jan;41(1):76-88.

67-  Amirifar P, Yazdani R, Azizi G, Ranjouri MR, Durandy A, Plebani A, Lougaris V, Hammarstrom L, Aghamohammadi A, Abolhassani H*. Known and Potential Molecules Associated with Altered B cell Development Leading to Predominantly Antibody Deficiencies. Pediatr Allergy Immunol. 2021 Nov;32(8):1601-1615.

68-  Khalili A, Yadegari AH, Delavari S, Yazdani R, Abolhassani H. Disseminated Intravascular Coagulation Associated with Large Deletion of Immunoglobulin Heavy Chain. Iran J Allergy Asthma Immunol. 2021 Dec 8;20(6):778-783.

69-  Abolhassani H*, Wang Y, Hammarström L, Pan-Hammarström Q. Hallmarks of Cancers: Primary Antibody Deficiency versus Other Inborn Errors of Immunity. Front Immunol. 2021 Aug 17;12:720025.

70-  Aghamohammadi A, Abolhassani H, Rezaei N. Primary Immunodeficiency Diseases in Iran: Past, Present and Future. Arch Iran Med. 2021 Feb 1;24(2):118-124.

71-  Fekrvand S, Mozdarani H, Delavari S, Sohani M, Nazari F, Kiaee F, Bagheri Y, Azizi G, Hassanpour G, Mozdarani S, Abolhassani H, Aghamohammadi A, Yazdani R. Evaluation of Radiation Sensitivity in Patients with Hyper IgM Syndrome. Immunol Invest. 2021 Jul;50(5):580-596.

72-  Hafezi N, Zaki-Dizaji M, Nirouei M, Asadi G, Sharifinejad N, Jamee M, Rasouli SE, Hamedifar H, Sabzevari A, Chavoshzadeh Z, Yazdani R, Abolhassani H, Aghamohammadi A, Azizi G. Clinical, Immunological, and Genetic Features in 780 Patients with Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-like diseases: A Systematic Review. Pediatr Allergy Immunol. 2021 Oct;32(7):1519-1532.

73-  Sharifinejad N, Zaki-Dizaji M, Tebyanian S, Zainaldain H, Jamee M, Rizvi FS, Hosseinzadeh S, Fayyaz F, Hamedifar H, Sabzevari A, Matloubi M, Heropolitańska-Pliszka E, Aghamahdi F, Abolhassani H, Azizi G. Clinical, Immunological, and Genetic Features in 938 Patients with Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED): a Systematic Review. Expert Rev Clin Immunol. 2021 Aug;17(8):807-817.

74-  Darbeheshti F, Abolhassani H, Bashashati M, Ghavami S, Shahkarami S, Zoghi S, Gupta S, Orange JS, Ochs HD, Rezaei N. Coronavirus: Pure Infectious Disease or Genetic Predisposition. Adv Exp Med Biol. 2021;1318: 91-107.

75-  Maródi L, Abolhassani H, J Project Study group et al. The 10th anniversary of the world primary immunodeficiency week: A J Project celebration. Eur J Immunol. 2021 Oct;51(10):2364-2366.

76-  Karimi E, Mahmoudian F, Reyes SOL, Bargir UA, Madkaikar M, Artac H, Sabzevari A, Lu N, Azizi G, Abolhassani H*. Approach to Genetic Diagnosis of Inborn Errors of Immunity through Next-Generation Sequencing.  Mol Immunol. 2021 Jun 30;137:57-66.

77-  Sancho-Shimizu V, Brodin P, Cobat A, Biggs CM, Toubiana J, Lucas CL, Henrickson SE, Belot A; MIS-C@CHGE (Haddad, Beland, Pujol, Schlüter, Planas-Serra, Aguilera-Albesa, Valencia-Ramos, Rodríguez-Palmero, Gut, Rivière, Colobran, Soler-Palacin, Rodriguez-Gallego, Perez De Diego, Flores, Alsina, Blazquez-Gamero, Jordan, Keles, Emiroglu, Metin Akcan, Alkan, Aytekin, Gul, Tüter Öz, Bozdemir, Bayhan, Yüksek, Parlakay, Gülhan, Yahşi, Kilic, Karbuz, Erdeniz Özkan, Orbak, Aydemir, Celik, Kandemir, Aytekin, Kapakli, Yarar, Alper Yosunkaya, Vatansev, Aytekin, Torun, Nepesov, Coskuner, Sözeri, Demirkol, Kasapcopur, Yıldız, Sevketoglu, Hatipoğlu, Özçelik, Yesilbas, Aydin, Sediva, Klocperk, Bloomfield, Meyts, Delafontaine, Haerynck, Hoste, Shahrooei, Marque, Neves, Novelli, Novelli, Aiuti, Casari, Bousfiha, Almuhsen, Sobh, Gagro, Bajolle, Bonnet, Lebon, Lei, Lee, Seeleuthner, Zhang, Maglorius, Philippot, Pelham, Bastard, Zhang, Jouanguy, Puel, Herberg, Kuijpers, Bellos, Kaforou, Menikou, Pan-Hammarström, Hammarström, Abolhassani H, Bryceson, Condino-Neto, Prando, Bando, Cavalcanti, Fellay, Blanchard-Hohner, Mansouri, Mahmoudi, Boyarchuk, Volokha, Bondarenko, Stepanovskiy, Mogensen, van de Beek, Andreakos, Papadaki, Tayoun, Halwani, Al-Mulla, Franco, Lau, Kwan, Imai, Okada, Bolze, Butte, Hsieh, Drolet, Arkin, Itan, Maniatis, Arditi, Cooper, Schmitt, Chakravorty, Anderson, Su, Notarangelo), Tangye SG, Milner JD, Levin M, Abel L, Bogunovic D, Casanova JL, Zhang SY.SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?. J Exp Med. 2021 Jun 7;218(6):e20210446.

78-  Safarirad M, Ganji AA, Nazari F, Yazdani R, Abolhassani H, Motlagh AV. Transient increased immunoglobulin levels in a hyper-IgM syndrome patient with COVID-19 infection. Allergol Immunopathol (Madr). 2021 Nov 1;49(6):63-66.

79-  Sherina N, Piralla A, Du L, Wan H, Kumagai-Braesh M, Andréll J, Braesch-Andersen S, Cassaniti I, Percivalle E, Sarasini A, Bergami F, Di Martino R, Colaneri M, Vecchia M, Sambo M, Zuccaro V, Bruno R, Oggionni T, Meloni F, Abolhassani H, Bertoglio F, Schubert M, Byrne-Steele M, Han J, Hust M, Xue Y, Hammarström L, Baldanti F, Marcotte H, Pan-Hammarström Q. Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection. Med. 2021.12;2(3):281-295.

80-  Abolhassani H*. Specific Immune Response and Cytokine Production in CD70 deficiency. Front Pediatr. 2021. Apr 30;9:615724.

81-  Abolhassani H, Hammarström L, Cunningham-Rundles C. Current genetic landscape of CVID. Blood. 2020 Feb 27;135(9):656-667.

82-  Micah AE, Su Y, Bachmeier SD, Chapin A, Cogswell IE, Crosby SW, Cunningham B, Harle AC, Maddison ER, Moitra M, Sahu M, Schneider MT, Simpson KE, Stutzman HN, Tsakalos G, Zende RR, Zlavog BS, Abbafati C, Abebo ZH, Abolhassani H, et al. Health Sector Spending and Spending on HIV/AIDS, Tuberculosis, and Malaria, and Development Assistance for Health: Progress Towards Sustainable Development Goal 3. Lancet. 2020 5-11 Sep;396(10252):693-724.

83-  Ghosh S, Köstel Bal S, Edwards ESJ, Pillay B, Jimenez-Heredia R, Rao G, Erol Cipe F, Salzer E, Zoghi S, Abolhassani H, et al. Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency. Blood. 2020 Dec 3;136(23):2638-2655.

84-  Lozano R, Fullman N, Mumford JE, Knight M, Barthelemy CM, Abbafati C, Abbastaba Hr, Abd-Allah F, Abdollahi M, Abedi A, Abolhassani H, et al. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1250-1284.

85-  Etemadi A, Safiri S, Sepanlou S, Ikuta K, Bisignano C, Shakeri R, Amani M, Fitzmaurice M, Nixon M, Abbasi N, Abolhassani H, et al. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017. The Lancet Gastroenterology & Hepatology. 2020 Jan;5(1):42-54.

86-  Kinyoki DK, Ross JM, Lazzar-Atwood A, Munro SB, Schaeffer LE, Abbasalizad-Farhangi M, Abbasi M, Abbastabar H, Abdelalim A, Abdoli A, Abdollahi M, Abdollahpour I, Abdulkader RS, Abebe ND, Abebo TA, Abegaz KH, Abolhassani H, et al. Mapping Local Patterns of Childhood Overweight and Wasting in Low- And Middle-Income Countries Between 2000 and 2017. Nat Med. 2020 May;26(5):750-759.

87-  Alatab S, Sepanlou S, Ikuta K, Vahedi H, Bisignano C, Safiri S, Sadeghi A, Nixon M, Abdoli A, Abolhassani H, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology. 2020 Jan;5(1):17-30.

88-  Abolhassani H, El-Sherbiny Y, Arumugakani G, Carter C, Richards S, Lawless D, Wood P, Buckland M, Heydarzadeh M, Aghamohammadi A, Hambleton S, Hammarström L, Burns S, Doffinger R, Savic S. Expanding clinical phenotype and novel insights into pathogenesis of ICOS deficiency. J Clin Immunol. 2020 Feb;40(2):277-288.

89-  Tesch VK, Abolhassani H, Shadur B, Zobel J, Mareika Y, Sharapova S, Karakoc-Aydiner E, Rivière J, Garcia-Prat M, Moes N, Haerynck F, Gonzales- Granado L, Pérez JL, Mukhina A, Shcherbina A, Aghamohammadi A, Hammarström L, Dogu F, Haskologlu S, İkincioğulları A, Bal S, Baris S, Kilic S, Karaca NE, Kutukculer N, Girschick H, Kolios A, Keles S, Uygun V, Stepensky P, Worth A, van Montfrans J, Peters A, Meyts I, Adeli M, Marzollo A, Nurcicek P, Khojah A, Chavoshzadeh Z, Stefanija MA, Bakhtiar S, Florkin B, Meeths M, Gamez L, Grimbacher B, Seppänen M, Lankester A, Gennery AR, Seidel M. Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score. J Allergy Clin Immunol. 2020. May;145(5):1452-1463.

90-  Abolhassani H, Lim CK, Aghamohammadi A, Hammarström L. Histocompatibility Complex Status and Mendelian Randomization Analysis in Unsolved Antibody Deficiency. Front Immunol. Front Immunol. 2020 Jan 24;11:14.

91-  Rizvi FS, Zainaldain H, Rafiemanesh H, Jamee M, Hossein-Khannazer N, Hamedifar H, Sabzvari A, Yazdani R, Abolhassani H, Aghamohammadi A, Azizi G. Autoimmunity in Common Variable Immunodeficiency: A Systematic Review and Meta-Analysis. Expert Rev Clin Immunol. 2020 Dec;16(12):1227-1235.

92-  Salami F, Shirkani A, Shahrooei M, Azizi G, Yazdani R, Abolhassani H, Aghamohammadi A. Leishmaniasis and autoimmunity in patient with LPS-responsive beige-like anchor protein (LRBA) deficiency. Endocr Metab Immune Disor